Pedro Coelho

Pedro Coelho is the founder and CEO of Biorce, a Barcelona-based health AI company building software that designs and manages clinical trials in minutes instead of months. A Portuguese entrepreneur with over eight years in life sciences consulting, he started Biorce after a clinical trial bought his father, who was dying of melanoma, ten extra months of life. In February 2026 the company closed a $52M Series A led by DST Global, the largest Series A in Iberian healthtech and AI, backed by angels including the CEOs of Mistral, Revolut, OutSystems and Seedtag.